Literature DB >> 28801448

Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.

Antonio Salar1, Eva Domingo-Domenech2, Carlos Panizo3, Concepción Nicolás4, Joan Bargay5, Ana Muntañola6, Miguel Canales7, José Luis Bello8, Juan Manuel Sancho9, José Francisco Tomás10, María José Rodríguez11, Javier Peñalver12, Carlos Grande13, José Javier Sánchez-Blanco14, Luis Palomera15, Reyes Arranz16, Eulogio Conde17, Mar García18, Juan Fernando García19, Dolores Caballero20, Carlos Montalbán10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28801448     DOI： 10.1182/blood-2017-07-795302

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  23 in total

Review 1.  Marginal Zone Lymphoma: State-of-the-Art Treatment.

Authors:  Ariel Sindel; Taha Al-Juhaishi; Victor Yazbeck
Journal:  Curr Treat Options Oncol       Date:  2019-12-05

Review 2.  Effective management strategies for patients with marginal zone lymphoma.

Authors:  Cecilia B Rosand; Kelly Valla; Christopher R Flowers; Jean L Koff
Journal:  Future Oncol       Date:  2017-12-20       Impact factor: 3.404

Review 3.  How do we sequence therapy for marginal zone lymphomas?

Authors:  Alessandro Broccoli; Pier Luigi Zinzani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

4.  The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas.

Authors:  Sean I Tracy; Melissa C Larson; Andrew L Feldman; Matthew J Maurer; Anne J Novak; Susan L Slager; Jose C Villasboas; Cristine Allmer; Thomas M Habermann; Umar Farooq; Sergei Syrbu; James R Cerhan; Brian K Link
Journal:  Am J Hematol       Date:  2019-04-10       Impact factor: 10.047

5.  Gastric MALT Lymphoma: A 8-Year Experience.

Authors:  Maria Eduarda Couto; Isabel Oliveira; Nelson Domingues; Luísa Viterbo; Ângelo Martins; Ilídia Moreira; Ana Espírito Santo; Sérgio Chacim; Cláudia Moreira; Dulcineia Pereira; Rui Henrique; José Mariz
Journal:  Indian J Hematol Blood Transfus       Date:  2021-08-26       Impact factor: 0.915

Review 6.  Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives.

Authors:  Dominic Kaddu-Mulindwa; Lorenz Thurner; Konstantinos Christofyllakis; Moritz Bewarder; Igor Age Kos
Journal:  Cancers (Basel)       Date:  2022-06-19       Impact factor: 6.575

7.  Prolonged complete remission in a primary MALT lymphoma of the lung after rituximab monotherapy.

Authors:  M D Diamantidis; S Chatzileontiadou; D Pantelidou; M Papaioannou
Journal:  Hippokratia       Date:  2017 Apr-Jun       Impact factor: 0.471

Review 8.  Treatment of indolent lymphoma.

Authors:  Seong Hyun Jeong
Journal:  Blood Res       Date:  2022-04-30

9.  Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version).

Authors:  Jun Zhu; Jun Ma
Journal:  Chin J Cancer Res       Date:  2021-06-30       Impact factor: 5.087

10.  Tailoring treatment for MALT lymphoma patients: where do we stand now?

Authors:  Peter W Johnson; Catherine Thieblemont; Emanuele Zucca
Journal:  Oncotarget       Date:  2017-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.